Cargando…
Understanding the Clinical Use of Levosimendan and Perspectives on its Future in Oncology
Drug repurposing, also known as repositioning or reprofiling, has emerged as a promising strategy to accelerate drug discovery and development. This approach involves identifying new medical indications for existing approved drugs, harnessing the extensive knowledge of their bioavailability, pharmac...
Autores principales: | Ribeiro, Eduarda, Vale, Nuno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526140/ https://www.ncbi.nlm.nih.gov/pubmed/37759695 http://dx.doi.org/10.3390/biom13091296 |
Ejemplares similares
-
Levosimendan: current data, clinical use and future development
por: Nieminen, M S, et al.
Publicado: (2013) -
Understanding Lamotrigine’s Role in the CNS and Possible Future Evolution
por: Costa, Bárbara, et al.
Publicado: (2023) -
Evaluation of synergism in drug combinations and reference models for future orientations in oncology
por: Duarte, Diana, et al.
Publicado: (2022) -
Entecavir: A Review and Considerations for Its Application in Oncology
por: Lourenço, Tânia, et al.
Publicado: (2023) -
Repurposing of the Drug Tezosentan for Cancer Therapy
por: Ribeiro, Eduarda, et al.
Publicado: (2023)